Combination therapy for Type 2 diabetes: repaglinide plus rosiglitazone

This publication has 10 references indexed in Scilit:

• The Prevention or Delay of Type 2 Diabetes
  Diabetes Care, 2002
• Insulin resistance syndrome and type 2 diabetes mellitus
  The American Journal of Cardiology, 2001
• Dyslipidaemia and diabetes
  Practical Diabetes International, 2001
• New Oral Therapies for Type 2 Diabetes Mellitus: The Glitazones or Insulin Sensitizers
  Annual Review of Medicine, 2001
• Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.
  Diabetes Care, 2000
• Pharmacokinetics, Pharmacodynamics, and Dose-Response Relationship of Repaglinide in Type 2 Diabetes
  Diabetes Technology & Therapeutics, 1999
• A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.
  Diabetes Care, 1999
• Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
  Diabetes Care, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998